Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.
Most drug stocks have been out of favor in 2023.
Pfizer was down 43.4% as of the market close Monday, while
weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.